Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
10x Genomics Inc (TXG)
NASDAQ:TXG
10x Genomics (TXG) Ownership - Who Owns 10x Genomics?
809 Followers
10x Genomics (TXG) Ownership Overview
17.85% Insiders
34.06% Mutual Funds
21.05% Other Institutional Investors
27.04% Public Companies and
Individual Investors
The ownership structure of 10x Genomics (TXG) stock is a mix of institutional, retail and individual investors. Approximately 55.11% of the company’s stock is owned by Institutional Investors, 17.85% is owned by Insiders and 27.04% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| May 23, 2024 | Serge Saxonov Ceo,director | Sold | $118511 |
| May 23, 2024 | Benjamin J. Hindson President And Chief Scientific Officer,director | Sold | $99314 |
| Mar 06, 2024 | Serge Saxonov Ceo,director | Sold | $204993 |
| Feb 26, 2024 | Serge Saxonov Ceo,director | Sold | $130725 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Mar 31, 2024 | Bought | $284815 | |
| Mar 31, 2024 | Bought | $2979882 | |
| Mar 31, 2024 | Bought | $3950445 | |
| Mar 31, 2024 | Bought | $18921650 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 9,465,828 | Institution | 8.96% | 165,557,332 | |
| 8,804,695 | Institution | 8.33% | 153,994,116 | |
| 8,277,076 | Institution | 7.83% | 144,766,059 | |
| 6,283,812 | Institution | 5.95% | 109,903,872 | |
| 4,058,916 | Institution | 3.84% | 70,990,441 | |
| 3,383,141 | Institution | 3.20% | 59,171,136 | |
| 2,366,475 | Institution | 2.24% | 41,389,648 | |
| 1,816,340 | Institution | 1.72% | 31,767,787 | |
| 1,651,460 | Institution | 1.56% | 28,884,035 | |
| 1,611,400 | Institution | 1.53% | 28,183,386 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 8,277,076 | Institution | 7.83% | 144,766,059 | |
| 4,058,916 | Institution | 3.84% | 70,990,441 | |
| 1,816,340 | Institution | 1.72% | 31,767,787 | |
| 1,651,460 | Institution | 1.56% | 28,884,035 | |
| 1,611,400 | Institution | 1.53% | 28,183,386 | |
| 1,338,646 | Institution | 1.27% | 23,412,919 | |
| 1,249,511 | Institution | 1.18% | 21,853,947 | |
| 1,111,000 | Institution | 1.05% | 19,431,390 | |
| 1,009,700 | Institution | 0.96% | 17,659,653 | |
| 1,003,439 | Institution | 0.95% | 17,550,148 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 7,187,362 | Institution | 6.80% | 125,706,961 | |
| 2,974,691 | Institution | 2.82% | 66,692,572 | |
| 2,413,390 | Institution | 2.28% | 54,108,204 | |
| 2,278,466 | Institution | 2.16% | 39,850,370 | |
| 1,568,656 | Institution | 1.48% | 35,169,268 | |
| 1,373,541 | Institution | 1.30% | 30,794,789 | |
| 719,525 | Institution | 0.68% | 12,584,492 | |
| 499,662 | Institution | 0.47% | 8,489,257 | |
| 320,487 | Institution | 0.30% | 7,185,319 | |
| 371,420 | Institution | 0.35% | 6,496,136 |
FAQ
Who Owns 10x Genomics Inc (TXG)?
According to the latest TipRanks data, approximately 21.05% of the company's stock is held by institutional investors, 17.85% is held by insiders, and 27.04% is held by retail investors.
What percentage of 10x Genomics Inc (TXG) stock is held by institutional investors?
According to the latest TipRanks data, approximately 21.05% of 10x Genomics Inc (TXG) stock is held by institutional investors.
What percentage of 10x Genomics Inc (TXG) stock is held by retail investors?
According to the latest TipRanks data, approximately 27.04% of 10x Genomics Inc (TXG) stock is held by retail investors.
Who owns the most shares of 10x Genomics Inc (TXG)?
ARK owns the most shares of 10x Genomics Inc (TXG).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.